Applying Knowledge . . Improving lives  
Welcome Guest (LOGIN)
     
 

search



Education & Meetings

Sexual Medicine: Management of Female Sexual Dysfunction

13.75 AMA PRA Category 1 Credits™

Las Vegas, NV

December 4–5, 2009

   

Register Now

   

Rate deadline at the Ritz-Carlton Lake Las Vegas is November 17

Course Director
Irwin Goldstein, MD

Target Audience
This course is designed for general urologists, urogynecologists, female urologists, neurourologists, uro-oncologists, andrologists, nurse practitioners, physician assistants, allied health professionals and other non-physician providers performing female sexual dysfunction clinical trials.

Course Description/Purpose/Need
This course will provide attendees who may already see women presenting with urologic conditions with the basic science principles and a rational, step-care clinical paradigm to better care for women’s sexual health concerns. Diagnostic strategies to be discussed will include history and physical examination, use of vulvoscopy, quantitative sensory testing, blood tests and genital blood flow testing. Management strategies to be discussed will include pelvic floor physical therapy, pharmacologic treatments (hormonal and non-hormonal) and surgical management. This learning experience will include didactic lectures, question-and-answer sessions, case studies with ample discussion for emphasis of critical points and extensive handout materials for future reference by attendees.

Learning Objectives
Upon completion of this course, participants should be able to:

  • interpret the current state of the art in basic science, physiology and pathophysiology of female sexual function and dysfunction
  • describe the multi-disciplinary nature of the step-care treatment paradigm for female sexual dysfunction
  • determine when a referral to a psychologist, physical therapist and/or sexual medicine physician is required for the woman with sexual dysfunction
  • diagnose and treat with sex steroid hormones and other medical therapies a woman with sexual dysfunction presenting in a community setting
  • identify when a woman with sexual dysfunction should consider surgical options

Scientific Program Schedule

Friday, December 4, 2009

7 – 8 a.m.

   

Continental Breakfast and Registration

8 – 8:10 a.m.

   

Introduction
Irwin Goldstein, MD

8:10 – 8:25 a.m.

   

The Top Ten Reasons Why Urologists Should Treat Female Sexual Dysfunction
Irwin Goldstein, MD

8:25 – 8:55 a.m.

   

Evidence-Based Scientific Studies: Physiology of Female Sexual Dysfunction
Noel N. Kim, PhD

8:55 – 9:25 a.m.

   

Evaluation of Women with Sexual Health Concerns: History, Physical Examination and Psychologic Interview
Andrew T. Goldstein, MD

9:25 – 9:45 a.m.

   

Break

9:45 – 10:15 a.m.

   

Evaluation of Women with Sexual Health Concerns: Hormonal Testing, Neurologic Testing and Blood Flow Testing
Irwin Goldstein, MD

10:15 – 10:45 a.m.

   

Evidence-Based Scientific Studies: Pathophysiology of Female Sexual Dysfunction
Noel N. Kim, PhD

10:45 – 11:15 a.m.

   

Links between Urinary Dysfunction and Female Sexual Dysfunction
Kristene E. Whitmore, MD

11:15 – 11:30 a.m.

   

Links between Other Urologic Disorders and Female Sexual Dysfunction
Kristene E. Whitmore, MD

11:30 a.m. – Noon

   

The Couple: Are Sexual Problems and Sexual Solutions Shared?
Susan Kellogg-Spadt, PhD, CRNP

Noon – 1 p.m.

   

Lunch with the Experts: Roundtable Discussions

1 – 1:30 p.m.

   

Modification of Reversible Causes
Susan Kellogg-Spadt, PhD, CRNP

1:30 – 2 p.m.

   

Hormonal Treatment with Systemic Androgens: Risks and Benefits
Irwin Goldstein, MD

2 – 2:30 p.m.

   

Hormonal Treatment with Systemic and Topical Estradiol: Risks and Benefits
Andrew T. Goldstein, MD

2:30 – 2:50 p.m.

   

Break

2:50 – 3:20 p.m.

   

Non-Hormonal Pharmacologic Treatments: Dopamine Agonists and Vasoactive Agents
Irwin Goldstein, MD

3:20 – 3:50 p.m.

   

Non-Surgical Treatment of Women with Sexual Pain Disorders (Physical Therapy, Interferon and Botox)
Susan Kellogg-Spadt, PhD, CRNP

3:50 – 4:20 p.m.

   

Treating Women with Urinary Dysfunction and Female Sexual Dysfunction
Kristene E. Whitmore, MD

Meeting Adjourns

Saturday, December 5, 2009

7:30 – 8 a.m.

   

Continental Breakfast

8 – 8:30 a.m.

   

Questions from Friday's Session

8:30 – 9:10 a.m.

   

Surgical Treatments for Women with Sexual Dysfunction
Andrew T. Goldstein, MD

9:10 – 9:40 a.m.

   

How to Open a Women’s Sexual Health Clinic
All Faculty

9:40 – 10 a.m.

   

Break

10 – 11 a.m.

   

Discussion and Case Presentation

11 a.m. – Noon

   

Break-Out Sessions A, B, C

Noon – 1 p.m.

   

Lunch with the Experts: Roundtable Discussions

1 – 2 p.m.

   

Break-Out Sessions A, B, C

2 – 3 p.m.

   

Break-Out Sessions A, B, C

Break-Out Sessions
Session A
Management of Sexual Pain
Office Management of Women’s Sexual Health
Andrew T. Goldstein, MD
Susan Kellogg-Spadt, PhD, CRNP

Session B
Urinary Tract Dysfunction
Female Sexual Dysfunction
Kristene E. Whitmore, MD

Session C
How and Why: Case Reports of Management of Women with Sexual Health Concerns
Irwin Goldstein, MD
Noel N. Kim, PhD

3 – 3:20 p.m.

   

Questions and Answers
All Faculty

Meeting Adjourns

Course Director
Irwin Goldstein, MD
Clinical Professor of Surgery
University of California, San Diego
Director, Sexual Medicine
Alvarado Hospital
San Diego, CA
Editor-in-Chief, The Journal of Sexual Medicine

Faculty
Andrew T. Goldstein, MD, FACOG
George Washington University School of Medicine and Health Sciences
Associate Clinical Professor
Department of Obstetrics and Gynecology
Director, The Centers for Vulvovaginal Disordersv
Washington, DC; Annapolis, MD; and New York, NY

Noel N. Kim, PhD
Vice President & Chief Scientific Officer
Senior Investigator
The Institute for Sexual Medicine
Alagin Research, LLC
San Diego, CA

Susan Kellogg-Spadt, PhD, CRNP
Professor, OBGYN
Drexel University College of Medicine
Professor, Human Sexuality
Widener University
Director of Sexual Medicine
The Pelvic & Sexual Health Institute
Philadelphia, PA

Kristene E. Whitmore, MD
Medical Director, Pelvic and Sexual Health Institute
Professor and Chair of Urology and Female Pelvic Medicine and Reconstructive Surgery
Director, Female Pelvic Medicine and Reconstructive Surgery Fellowship
Drexel University College of Medicine
Philadelphia, PA

Hotel and Transportation Information

Venture into an unexpected oasis where the desert gives way to a sparkling lake and gleaming white beach just 17 miles from the Las Vegas strip. The Ritz-Carlton, Lake Las Vegas surprises travelers by combining the best of the desert with lush grounds and a romantic, Tuscan-inspired setting.

Telephone:    702-567-4700
Fax:    702-567-4777
To hold a reservation, a major credit card number must be provided.
Guest Room Rate:    $129 single/double occupancy.
Reference the AUA Female Sexual Dysfunction meeting to receive the special group rate.
Cut-off Date:    November 17, 2009
Guest rooms may not be available at the AUA special rate after this date. Once the group room block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.
Address:    1610 Lake Las Vegas Parkway
Henderson, NV 89011
Web site:    www.ritzcarlton.com
Check In:    3 p.m.
Check Out:    Noon
Parking:    Overnight valet parking is $20 per day.
Transportation:    Cab fare from McCarran International Airport is ?approximately $50–$60 and takes approximately 20–30 minutes depending on the time of day.
Car Rental:    Avis is offering special discounted rates to all meeting attendees. Reservations can be made by calling 1-800-331-1600 and reference the AUA Avis World Wide Discount (AWD) number J907607 or visit www.avis.com. Be sure to enter the AWD number J907607 and "Best" in the rate code to receive the available discount.

Registration Fees and Information

AUA Member    $600
Non-member    $725
Residents/Fellows/Allied Health Professional Members    $300
Residents/Fellows/Allied Health Professional Non-members    $425

Cancellation Policy
Through Friday, November 6, 2009 the cancellation fee is $125. Cancellations received after this date will be refunded minus a $150 administrative fee. No registration fees will be refunded after Friday, November 20, 2009. The AUA has the right to cancel this course if a minimum enrollment is not reached by Monday, November 9, 2009. If the AUA cancels this course, registration fees will be refunded in full and notification will be sent by Wednesday, November 11, 2009.

Course Confirmation
A written confirmation will be sent from our office approximately two weeks after your registration is received and processed. We do not recommend the purchase of airline tickets until your registration is confirmed in writing or by telephone by the AUA.

CME Information

Continuing Medical Education Accreditation
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

The AUA takes responsibility for the content, quality and scientific integrity of this CME activity.

Credit Designation
The AUA designates this educational activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AUA Disclosure Policy
As a provider accredited by the ACCME, the AUA must ensure balance, independence, objectivity and scientific rigor in all its activities.

All faculty participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments.

Unlabeled or Unapproved Use of Drugs or Devices
It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this CME activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Evidence-Based Content
As a provider of CME accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous and free of commercial bias.

Audio, Video and Photographic Equipment
Audio, video and other photographic recording equipment is prohibited inside AUA meeting rooms.

Special Assistance
We encourage participation by all individuals. If you have a disability or any special dietary requirements, advance notification of any special needs will help us better serve you. Call 410-689-4002 at least one month prior to the course if you require special assistance to fully participate in the meeting.

Questions?
Call 1-800-908-9414 or e-mail registration@AUAnet.org.